Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders

1. Endocannabinoids and Monoamines: Modulating the Modulators
Elisabeth J. Van Bockstaele

2. Endocannabinoid-Mediated Synaptic Plasticity
Ken Mackie

3. Current Cannabinoid Receptor Nomenclature and Pharmacological Principles
Jahan Marcu, Linda Console-Bram, Mary E. Abood

4. Cue-Elicited Craving for Cannabis Activates the Reward Neurocircuitry Associated with the Neuropathology of Addiction
Samuel J. DeWitt, Sven Kroener, Francesca M. Filbey

5. Cannabinoid Modulation of Dopaminergic Circuits in Neurodegenerative and Neuropsychiatric Disorders
Julien Matricon, Andrea Giuffrida

6. Pathophysiology of Mood Disorders and Mechanisms of Action of Antidepressants and Mood Stabilizers
Zdeněk Fišar

7. Anatomical, Biochemical, and Behavioral Evidence for Cannabinoid Modulation of Noradrenergic Circuits: Role of Norepinephrine in Cannabinoid-Induced Aversion
Ana Franky Carvalho, Elisabeth J. Van Bockstaele

8. Gender Disparity of Depression: The Role of Endocannabinoids and Noradrenergic Function
Boris B. Gorzalka, Silvain S. Dang

9. Endocannabinoids, Monoamines and Stress
Cecilia J. Hillard

10. Chronic Effects of Cannabinoid Drugs on Monoaminergic Systems and the Role of Endocannabinoids and Cannabinoid Receptors in Human Brain Disorders
Leyre Urigüen, Susana Esteban, Luís F. Callado, María Álvaro-Bartolomé, J. Javier Meana, Jesús A. García-Sevilla

11. Endocannabinoid Signaling and the Regulation of the Serotonin System
Samir Haj-Dahmane, Roh-Yu Shen

12. Modulation of Serotonin Firing Activity Through CB1 Agonists and FAAH Inhibitors
Gabriella Gobbi

13. Involvement of Serotonergic System in Cannabinoid Analgesia
Ahmet Dogrul, Melik Seyrek, Bulent Yalcin, Ahmet Ulugol

14. Cannabinoids, Monoamines, COMT and Schizophrenia: Pathobiological Mechanisms in Psychosis
Colm M.P. O’Tuathaigh, Lieve Desbonnet, John L. Waddington

Nyckelord: Biomedicine, Neurosciences, Neurology, Psychiatry, Neurochemistry